US CRM probe: when putting a house in order means taking a step backwards
This article was originally published in Clinica
The release by the US Department of Justice of medical review guidelines to resolve claims in connection with alleged overuse of implantable cardioverter defibrillators (ICDs) was the logical next step in efforts to address an episode that has done little to build confidence in medical devices.
You may also be interested in...
COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.
Certain Cumberlege Review recommendations are making their way into draft UK legislation as the government presses ahead in shaping the UK’s post-Brexit devices regulatory system.
Delivering innovation is still the driving force for medtechs intent on growing in the market, regardless of COVID-19, the disruptive effects of which have intensified with the appearance of new variants, says Jefferies Healthcare equity analyst Raj Denhoy.